U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07254871) titled 'Study to Evaluate Safety and Efficacy of DM-101PX in Adults With Birch Pollen Allergy' on Sept. 23.
Brief Summary: Randomized, double-blind placebo-controlled phase 2 trial with the aim to investigate safety and efficacy of DM-101-PX in reducing allergic symptoms provoked by nasal allergen challenge in birch pollen allergic adults. Expanded access to the study treatment is not available.
Study Start Date: Sept. 26
Study Type: INTERVENTIONAL
Condition:
Birch Pollen Allergy
Intervention:
BIOLOGICAL: DM-101PX
subcutaneous injection of DM-101PX
BIOLOGICAL: Placebo
Placebo to match DM-101PX administered subcutaneously
Recruitme...